Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caleb Bliss

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Neuropsychiatric Disease and Treatment|March 3, 2018
Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studiesLeslie Citrome, Judith C Kando, Caleb Bliss
Retina (Philadelphia, Pa.)|August 3, 2023
CorrespondenceCaroline Baumal, Caleb Bliss, Daniel Jones, et al.
The Journal of Clinical Psychiatry|March 1, 2019
Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder: Analysis by Gender and AgeSusan G Kornstein, Caleb Bliss, Judith Kando, et al.
CNS Drugs|February 1, 2018
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine DimesylateDavid R Coghill, Tobias Banaschewski, Caleb Bliss, et al.
BMC Pharmacology & Toxicology|March 18, 2018
A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitisMelissa Palmer, Lee Jennings, Debra G Silberg, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|January 8, 2010
Screening and brief intervention to reduce marijuana use among youth and young adults in a pediatric emergency departmentEdward Bernstein, Erika Edwards, David Dorfman, et al.
Journal of Attention Disorders|August 25, 2017
Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHDDavid R Coghill, Alain Joseph, Vanja Sikirica, et al.
AIDS and Behavior|January 21, 2012
The impact of a brief motivational intervention on unprotected sex and sex while high among drug-positive emergency department patients who receive STI/HIV VC/T and drug treatment referral as standard of careEdward Bernstein, Desiree Ashong, Timothy Heeren, et al.
Annals of Surgery|August 26, 2011
Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patientsHarold L Lazar, Marie M McDonnell, Stuart Chipkin, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 14, 2017
Absorption, Distribution, Metabolism, and Excretion of [<sup>14</sup>C]-Volixibat in Healthy Men: Phase 1 Open-Label StudyNicholas Siebers, Melissa Palmer, Debra G Silberg, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Neuropsychiatric Disease and Treatment|March 3, 2018
Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studiesLeslie Citrome, Judith C Kando, Caleb Bliss
Retina (Philadelphia, Pa.)|August 3, 2023
CorrespondenceCaroline Baumal, Caleb Bliss, Daniel Jones, et al.
The Journal of Clinical Psychiatry|March 1, 2019
Clinical Characteristics and Treatment Response to Lisdexamfetamine Dimesylate Versus Placebo in Adults With Binge Eating Disorder: Analysis by Gender and AgeSusan G Kornstein, Caleb Bliss, Judith Kando, et al.
CNS Drugs|February 1, 2018
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine DimesylateDavid R Coghill, Tobias Banaschewski, Caleb Bliss, et al.
BMC Pharmacology & Toxicology|March 18, 2018
A randomised, double-blind, placebo-controlled phase 1 study of the safety, tolerability and pharmacodynamics of volixibat in overweight and obese but otherwise healthy adults: implications for treatment of non-alcoholic steatohepatitisMelissa Palmer, Lee Jennings, Debra G Silberg, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|January 8, 2010
Screening and brief intervention to reduce marijuana use among youth and young adults in a pediatric emergency departmentEdward Bernstein, Erika Edwards, David Dorfman, et al.
Journal of Attention Disorders|August 25, 2017
Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHDDavid R Coghill, Alain Joseph, Vanja Sikirica, et al.
AIDS and Behavior|January 21, 2012
The impact of a brief motivational intervention on unprotected sex and sex while high among drug-positive emergency department patients who receive STI/HIV VC/T and drug treatment referral as standard of careEdward Bernstein, Desiree Ashong, Timothy Heeren, et al.
Annals of Surgery|August 26, 2011
Effects of aggressive versus moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patientsHarold L Lazar, Marie M McDonnell, Stuart Chipkin, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 14, 2017
Absorption, Distribution, Metabolism, and Excretion of [<sup>14</sup>C]-Volixibat in Healthy Men: Phase 1 Open-Label StudyNicholas Siebers, Melissa Palmer, Debra G Silberg, et al.
Pageof 3